PRK14: PERCEIVED RISK, VALUE AND QUALITY OF LIFE FOR PATIENTS WITH OVERACTIVE BLADDER: DEVELOPMENT OF A PERCEIVED VALUE SCALE

Aim: To understand how patients with cancer reacted to the coronavirus disease 2019 (COVID-19) pandemic and whether their quality of life (QoL) was affected. Methods: In June 2020, 111 patients with cancer treated in the supportive care unit of a Comprehensive Cancer Center in Milan and 201 healthy controls from the general population were enrolled and assessed both quantitatively and qualitatively for fears and COVID-19–related beliefs as well as for QoL. Results: Fear of COVID-19 was significantly lower among patients (41% vs 57.6%; p = 0.007), as was fear of cancer (61.5% vs 85.6%; p < 0.001) and other diseases. The perceived risk of getting COVID-19 was lower among patients (25.2% vs 52.7%; p < 0.001), as was the belief of having been exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (18.1% vs 40.8%; p < 0.001). The physical component of QoL was better among the population (54.5 vs 43.8; p < 0.001); the reverse was true for patients’ psychological well-being (44.6 vs 39.6; p < 0.001). The qualitative data supported such results, showing a reduced psychological effect on the patients with cancer compared to the controls. Various reasons explain this result, including the awareness of being treated for cancer and nevertheless protected against getting infected in a cancer center of public health reorganized to continue treating patients by protecting them and personnel from the risk of infection. Conclusions: The experience of a cancer diagnosis, together with proper hospital reorganization, may act as protective factors from fears and psychological consequences of the COVID-19 outbreak.

Download Full-text

Impact of Transdermal Oxybutynin on Quality of Life in Patients With Overactive Bladder

Obstetrics and Gynecology ◽

10.1097/00006250-200604001-00178 ◽

2006 ◽

Vol 107 (Supplement) ◽

pp. 74S-75S ◽

Cited By ~ 2

Author(s):

Vincent R. Lucente ◽

Roger P. Goldberg ◽

G Willy Davila ◽

Charles W. Gonick ◽

Robert Lamar Parker ◽

...

Keyword(s):

Quality Of Life ◽

Overactive Bladder

Download Full-text

The effect of the perceived value of cultural services on the quality of life

International Review on Public and Nonprofit Marketing ◽

10.1007/s12208-015-0140-9 ◽

2015 ◽

Vol 13 (1) ◽

pp. 15-36

Author(s):

Ida Ercsey ◽

László Józsa

Keyword(s):

Quality Of Life ◽

Perceived Value ◽

Cultural Services

Download Full-text

TOLTERODINE IMPROVES QUALITY OF LIFE IN PATIENTS WITH AN OVERACTIVE BLADDER, WITH OR WITHOUT URINARY INCONTINENCE: A PROSPECTIVE MULTICENTER STUDY

Urogynaecologia ◽

10.4081/uij.2008.1.5 ◽

2010 ◽

Vol 22 (1) ◽

pp. 5

Author(s):

F. Mantovani ◽

G. Bozzini ◽

P. Acquati ◽

S.S. Di Pierro ◽

M.G. Spinelli ◽

...

Keyword(s):

Quality Of Life ◽

Overactive Bladder ◽

Clinical Effects ◽

Health Questionnaire ◽

Prospective Multicenter Study ◽

Study Materials ◽

Trial Entry ◽

The Mean

AIMS: In order to analyse the effect of tolterodine on the Quality of life (QoL) of patients with overactive bladder (OB) we conducted a prospective multicentre clinical study. MATERIALS AND METHODS: Subjects were questioned at entry and 4, 12 and 24 weeks later about the number of micturitions and incontinent and urgency episodes/day, using a micturition diary. The mean volume voided per micturition and the number of pads used per day was also recorded. The QoL was measured using the Kings Health Questionnaire (KHQ) and the Incontinence Impact Questionnaire (IIQ). A total of 179 patients entered the study: 59 dropped out (4 due to lack of efficacy, 10 due to adverse events, 25 because of lack of interest in the study/other reason and 20 were lost at follow up), leaving 120 patients for analysis. One hundred and eight patients (90%) were female, their mean age was 56.5 years (SD 11.2); 87 had never received treatment for OB/UI (80.6%) and their mean weight was 70.0 Kg (SD 12.7). RESULTS: The mean number of micturitions/day was 9.3 at trial entry and it decreased to 6.8 by the end of the study. The corresponding values for the number of urge episodes, incontinence episodes and number of pads used per day were 3.5, 2.7 and 1.2 and 0.8, 0.9 and 0.4 respectively. The mean volume voided per micturition increased from 146 ml. to 178 ml. All the differences between trial entry and end of study values were statistically significant (p<0.05). Considering the results of the KHQ, the values of all the different areas/domini (?) decreased markedly and in a statistically significant way between the start of treatment and the end of study evaluations. Similar findings emerged when we considered values of the IIQ. The decrease was constant and marked during the first three months and remained constant thereafter. CONCLUSIONS: This study, conducted in a population of subjects with dry and wet OB, shows that tolterodine given for six months lowers the frequency of urgency episodes and incontinence episodes without troublesome adverse effects. These clinical effects are mirrored in the QoL, KHQ and IIQ questionnaire scores, which improved by about 50% over the same period.

Download Full-text